/
Category AstraZeneca
How Medicare’s new drug prices could reshape Novo Nordisk and european pharma
Medicare has negotiated steep new prices for 15 high-cost drugs, including Novo Nordisk’s blockbuster semaglutide (Wegovy and Ozempic), with negoti...
Nov, 26, 2025
3 min read
by Invezz
Europe markets open: Stoxx 600 falls 0.3% as earnings reports roll in
European stocks opened lower on Thursday as investors processed another heavy slate of corporate earnings reports, with strong results from some co...
Nov, 06, 2025
2 min read
by Invezz
Pharma giant AstraZeneca eyes NYSE listing overhaul, keeps London base
AstraZeneca announced plans to change how it lists shares in the United States by moving from American depositary receipts (ADRs) on Nasdaq to a di...
Sep, 29, 2025
2 min read
by Invezz
Eli Lilly CEO slams UK drug pricing: what’s behind the backlash?
Eli Lilly’s chief executive Dave Ricks has delivered a stark warning to the UK government, branding Britain “probably the worst country in Europe” ...
Sep, 24, 2025
4 min read
by Invezz
AstraZeneca pauses £200mn Cambridge investment amid UK pharma uncertainty
AstraZeneca has become the latest major drugmaker to scale back investment in the United Kingdom, pausing a planned £200 million ($271 million) exp...
Sep, 12, 2025
3 min read
by Invezz